Conor McNamara
Stock Analyst at RBC Capital
(1.27)
# 3,663
Out of 5,129 analysts
141
Total ratings
33.98%
Success rate
-12.45%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Upgrades: Outperform | $61 → $73 | $63.45 | +15.05% | 11 | Sep 3, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $7 → $5 | $3.12 | +60.26% | 7 | Aug 12, 2025 | |
| NTRA Natera | Maintains: Outperform | $251 → $255 | $212.46 | +20.02% | 2 | Aug 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $4 → $3 | $1.70 | +76.47% | 4 | Aug 7, 2025 | |
| EXAS Exact Sciences | Maintains: Sector Perform | $54 → $46 | $103.43 | -55.53% | 1 | Aug 7, 2025 | |
| HOLX Hologic | Upgrades: Outperform | $72 → $87 | $75.09 | +15.86% | 12 | Aug 6, 2025 | |
| AVTR Avantor | Maintains: Outperform | $20 → $17 | $9.64 | +76.35% | 9 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Outperform | $118 → $126 | $116.38 | +8.27% | 16 | Aug 1, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $293.69 | +39.26% | 14 | Aug 1, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $292.64 | +39.76% | 14 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $193 → $204 | $139.40 | +46.34% | 12 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $651 → $637 | $527.17 | +20.83% | 14 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $250 | $219.98 | +13.65% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $28.80 | +111.81% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $4.78 | +46.60% | 4 | Aug 7, 2024 |
Bio-Techne
Sep 3, 2025
Upgrades: Outperform
Price Target: $61 → $73
Current: $63.45
Upside: +15.05%
Maravai LifeSciences Holdings
Aug 12, 2025
Maintains: Outperform
Price Target: $7 → $5
Current: $3.12
Upside: +60.26%
Natera
Aug 8, 2025
Maintains: Outperform
Price Target: $251 → $255
Current: $212.46
Upside: +20.02%
OmniAb
Aug 7, 2025
Maintains: Outperform
Price Target: $4 → $3
Current: $1.70
Upside: +76.47%
Exact Sciences
Aug 7, 2025
Maintains: Sector Perform
Price Target: $54 → $46
Current: $103.43
Upside: -55.53%
Hologic
Aug 6, 2025
Upgrades: Outperform
Price Target: $72 → $87
Current: $75.09
Upside: +15.86%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $9.64
Upside: +76.35%
Illumina
Aug 1, 2025
Maintains: Outperform
Price Target: $118 → $126
Current: $116.38
Upside: +8.27%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $293.69
Upside: +39.26%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $292.64
Upside: +39.76%
Jul 30, 2025
Maintains: Outperform
Price Target: $193 → $204
Current: $139.40
Upside: +46.34%
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $527.17
Upside: +20.83%
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $219.98
Upside: +13.65%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $28.80
Upside: +111.81%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $4.78
Upside: +46.60%